Table 1.
Demographic and Clinical variables
| SSD Group (n = 64) | Controls (n = 26) | SSD vs. Control (p) | |
|---|---|---|---|
| Age | 23.02 (3.9) | 25.15 (7.1) | 0.12 |
| Education | 13.78 (2.1) | 13.50 (.91) | 0.51 |
| Sex (M/F) | 47/17 | 16/10 | 0.26 |
| Racial Background (%) | 0.01 | ||
| Caucasian | 48.4% | 46.2% | |
| Asian | 18.8% | 42.3% | |
| Black | 18.8% | 11.5% | |
| Other | 14.0% | 0% | |
| WTAR FSIQ | 107.18 (8.0) | 108.19 (14.6) | 0.68 |
| RFS Social Networks | 4.52 (1.6) | 6.15 (1.6) | < 0.001 |
| Duration of illness (months) | 30.17 (19.0) | -- | -- |
| Chlorpromazine Equivalents | 344.05 (351.9) | -- | -- |
| PANSS Positive subscale | 7.02 (3.7) | -- | -- |
| PANSS Negative Subscale | 13.88 (6.5) | -- | -- |
Note. WTAR = Wechsler Test of Adult Reading Scale; FSIQ = Full Scale IQ; RFS = Role Functioning Scale; PANSS = Positive and Negative Syndrome Scale.